首页>
外国专利>
Use of cholinesterase inhibitors to reduce benzodiazepine side effects
Use of cholinesterase inhibitors to reduce benzodiazepine side effects
展开▼
机译:胆碱酯酶抑制剂的使用减少苯二氮卓的副作用
展开▼
页面导航
摘要
著录项
相似文献
摘要
The use of a pharmaceutically acceptable cholinesterase inhibitor or a prodrug therefor for counteracting the sedative, hypnotic or respiratory depressive effects of benzodiazepines, substantially without interfering with the anxiolytic, antipsychotic, anticonvulsant, and muscle relaxant activity of benzodiazepines, especially the benzodiazepines used for treatment of diseases where the sedative, hypnotic or respiratory depressive effects are undesirable, such as diseases selected from the group consisting of anxiety, anxiety neurosis, anxiety reactions, panic reactions, schizophrenia, affective or schizoaffective type schizophrenia, borderline psychosis, agitating endogene depressions, hyperactivity in children, and muscle spasms. The acetyl cholinesterase is preferably one that acts substantially selectivity at nicotinic receptor sites, and which has selectively for acetyl cholinesterase opposed to butyryl cholinesterase, e.g. galanthamine or a galanthamine derivative.
展开▼